Press Release: MapmyGenome Partners with Lucid Diagnostics to Offer DNA Onco Screen™ for Cancer Screening
HYDERABAD, February 21, 2019 — Lucid Diagnostics, a premier diagnostics company, and MapmyGenome, a molecular diagnostics company, today announced their alliance to advance cutting-edge, personalised, and preventive medicine by combining genomics and pathology lab services. Lucid will offer DNA Onco Screen™ to customers and physicians for prevention and early detection of cancers.
“Genetics is an important part of clinical diagnostics and we are pleased to offer these packages with MapmyGenome.” — Dr Sunitha Lingareddy, Managing Director, Lucid Diagnostics
“We are quite excited about this partnership. Combining clinical parameters with genomics makes it very compelling for physicians and consumers to get a comprehensive screen.” — Anu Acharya, CEO, MapmyGenome
DNA Onco Screen™ assesses genetic predisposition to various cancers, physiological traits known to trigger cancer, and lifestyle traits linked to cancer risk. Key clinical markers associated with cancer are also tested. All packages include genetic counselling to help understand individuals’ risk of cancer, inheritance patterns, and lifestyle changes essential to prevent cancer.
About MapmyGenome
MapmyGenome™ is a molecular diagnostics company that encourages people to be proactive about their health. Founded in 2013 with a vision to “Touch 100 million lives and save a million lives by 2030,” MapmyGenome offers personalised health solutions based on genetic tests — combining genetic health profiles, health history, and genetic counselling to provide actionable steps for individuals and their physicians towards healthier lives. CAP & NABL-accredited laboratory.
About Lucid Diagnostics
Lucid provides a comprehensive suite of healthcare services and health check-up packages to aid accurate and timely diagnosis. Lucid Lab has been accredited with both NABL and CAP to achieve the highest standards of excellence. Currently running 69 centres in Telangana, Andhra Pradesh, and Karnataka.
Comprehensive Cancer Screening — Genetics + Pathology
Oncomap by MapmyGenome offers a comprehensive hereditary cancer risk panel. Genomepatri screens for 20+ cancer types. Both include certified genetic counselling and a CAP & NABL-accredited laboratory.
